| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/09/2004 | EP1425039A2 Human papilloma virus immunoreative peptides |
| 06/09/2004 | EP1425038A1 Attenuated bacteria useful in vaccines |
| 06/09/2004 | EP1425037A2 Bacterial vaccine |
| 06/09/2004 | EP1425036A2 Virus coat protein/receptor chimeras and methods of use |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1424906A1 Method and apparatus for separation of milk, colostrum, and whey |
| 06/09/2004 | EP1424897A2 Compositions and methods for treatment of cancer |
| 06/09/2004 | EP1054687A4 Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomas |
| 06/09/2004 | EP1036094A4 Cyp7 promoter-binding factors |
| 06/09/2004 | EP0934081B1 Antineoplastic conjugates of albumin |
| 06/09/2004 | EP0809510B1 Lymphotoxin-alpha/beta complexes and anti-lymphotoxin-beta receptor antibodies as anti-tumor agents |
| 06/09/2004 | EP0589928B1 Cold tolerances in plants |
| 06/09/2004 | EP0547164B1 Methods for the diagnosis and treatment of diabetes |
| 06/09/2004 | DE10156863B4 Verfahren zur Identifizierung von Zielepitopen der T-Zell-vermittelten Immunantwort und zum Nachweis Epitop-spezifischer T-Zellen A method for identifying target epitopes of the T-cell mediated immune response and for the detection of epitope-specific T-cells |
| 06/09/2004 | CN1503843A Vaccination against host cell-associated herpesviruses |
| 06/09/2004 | CN1503816A Agent for the prevention and treatment of sexually transmitted diseases-1 |
| 06/09/2004 | CN1503680A Ascorbic a cid analogs for metalloradiopharmaceuticals |
| 06/09/2004 | CN1502698A Methods for the recombinant production of antifusogenic peptides |
| 06/09/2004 | CN1502697A Alzhimer's disease secretase |
| 06/09/2004 | CN1502696A Alzheimer's disease secretase |
| 06/09/2004 | CN1502692A Alzheimer's disease secretase |
| 06/09/2004 | CN1502629A Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/09/2004 | CN1502628A Polyglycol modification article for acidic fibroblast growth factor and its mutant |
| 06/09/2004 | CN1502627A Human tumor relative gene CT120 in human 17p 13.3 area and coding protein thereof |
| 06/09/2004 | CN1502626A Novel human protein with cancer-inhibiting function and coding sequence thereof |
| 06/09/2004 | CN1502331A Anti-angiogenic compositions and methods of use |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/09/2004 | CN1152961C Transcription factor controlling phenylpropanol biosynthesis pathway |
| 06/09/2004 | CN1152960C ICAM-4 materials and methods |
| 06/09/2004 | CN1152887C Hydrolytic active substance of brain protein, its preparing process and its activity and sequence |
| 06/08/2004 | US6747784 Compliant mechanism and method of forming same |
| 06/08/2004 | US6747189 Maize glycine rich protein promoter compositions and methods for use thereof |
| 06/08/2004 | US6747188 Nucleotide sequences for use in the generation of disease resistant plants |
| 06/08/2004 | US6747187 Knockout mouse for the tumor suppressor gene ANX7 |
| 06/08/2004 | US6747156 Method of producing 6-substituted (s)-nicotine derivatives and intermediate compounds |
| 06/08/2004 | US6747143 Methods for polymer synthesis |
| 06/08/2004 | US6747139 Nucleic acid encoding human thyrotropin receptor |
| 06/08/2004 | US6747138 Using protein that binds cytoplasmic region or domain of fas receptor |
| 06/08/2004 | US6747135 Fluorescent dye binding peptides |
| 06/08/2004 | US6747133 Antibodies against the tumor suppressor gene ING1 |
| 06/08/2004 | US6747132 Methods for the synthesis of a modified hemoglobin solution |
| 06/08/2004 | US6747131 Phosphorylated fusion proteins |
| 06/08/2004 | US6747130 Tenebrio antifreeze proteins |
| 06/08/2004 | US6747129 Target of RNAIII activating protein(TRAP) |
| 06/08/2004 | US6747126 Peptide inhibitors of HIV entry |
| 06/08/2004 | US6747013 Such as rheumatoid arthritis; gene therapy, such as to replace a defective apoptotic gene, to cells in the affected area |
| 06/08/2004 | US6747005 Determining importin alpha activities in presence and absence of camp-response element binding protein which acetylates importin alpha to determine effect on activities, comparing effect in presence and absence of test compound |
| 06/08/2004 | US6747004 Contacting embryonic forebrain cells in vitro with amount of endometrial bleeding associated factor protein having specified amino acid sequence effective to induce proliferation of forebrain cells |
| 06/08/2004 | US6747003 Modified vitamin K-dependent polypeptides |
| 06/08/2004 | US6747001 Bioactive peptides, uses thereof and process for the production of same |
| 06/08/2004 | US6746871 Bacillus crystal proteins having improved insecticidal activity; immunodetection kits; transgenic plants |
| 06/08/2004 | US6746868 Chemical modification of DNA using peptide nucleic acid conjugates |
| 06/08/2004 | US6746867 Mammalian mesoderm induction early response (MIER) gene family |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746855 L-lysine-producing corynebacteria and process for the preparation of L-lysine |
| 06/08/2004 | US6746853 Proteins with insulin-like activity useful in the treatment of diabetes |
| 06/08/2004 | US6746852 Activator of g protein signaling, or ?ags?; recombinant expression vectors containing a nucleic acid molecule of the protein/nucleic acid |
| 06/08/2004 | US6746847 Diagnostic assay for human matrix Gla-protein and its use as a biomarker |
| 06/08/2004 | US6746846 Comprise tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions ;may comprise an antigen presenting cell |
| 06/08/2004 | US6746838 Protein which is capable of binding to any predefined nucleic acid sequence |
| 06/08/2004 | US6746837 Multiple drug resistance gene atrD of aspergillus nidulans |
| 06/08/2004 | US6746674 Cytostatin II |
| 06/08/2004 | US6746672 Isolated bifidobacteria that produce siderophores which inhibit growth of lactococcus lactis |
| 06/08/2004 | US6746671 Use of a cytokine-producing lactococcus strain to treat colitis |
| 06/08/2004 | US6746669 Method for down-regulating IL5 activity |
| 06/08/2004 | US6746668 Apo-2 ligand |
| 06/08/2004 | CA2262884C Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 06/08/2004 | CA2134535C Method for sterilizing recombinant human serum albumin pharmaceutical preparation |
| 06/08/2004 | CA2064814C Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 06/05/2004 | CA2410153A1 A novel bacillus thuringiensis strain, crystal gene and crystal protein and uses thereof |
| 06/03/2004 | WO2004046730A2 Uses of ble proteins and antibiotics from the bleomycin family |
| 06/03/2004 | WO2004046722A2 Scd40l, papp-a and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases |
| 06/03/2004 | WO2004046376A2 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll) |
| 06/03/2004 | WO2004046365A2 Interferon-alpha polypeptides and conjugates |
| 06/03/2004 | WO2004046363A1 Induced humoral immune response using promoters specifically active in antigen presenting cells |
| 06/03/2004 | WO2004046358A1 Novel cancer-associated gene |
| 06/03/2004 | WO2004046357A1 Organ preferential genes identified by t-dna insertional mutagenesis of rice |
| 06/03/2004 | WO2004046355A2 Protein specific to pancreatic beta cells in islets of langerhans and applications thereof |
| 06/03/2004 | WO2004046352A1 MUTANT ESTROGEN RECEPTOR-α AND GENE THEREOF |
| 06/03/2004 | WO2004046345A2 Use of hmgb fragments as anti-inflammatory agents |
| 06/03/2004 | WO2004046338A2 Use of hmgb polypeptides for increasing immune responses |
| 06/03/2004 | WO2004046336A2 Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway |
| 06/03/2004 | WO2004046332A2 Amplified genes involved in cancer |
| 06/03/2004 | WO2004046331A2 2’-branched nucleosides and flaviviridae mutation |
| 06/03/2004 | WO2004046323A2 Structure of the farnesoid x receptor ligand binding domain and methods of use therefor |
| 06/03/2004 | WO2004046319A2 Bacteriophage having modified holin and uses thereof |
| 06/03/2004 | WO2004046317A2 Products and processes for modulating peptide-peptide binding domain interactions |
| 06/03/2004 | WO2004046315A2 Compositions and methods utilizing human gamma-hydroxybutyrate receptor |
| 06/03/2004 | WO2004046311A2 A method for the crystallization of human serum albumin |
| 06/03/2004 | WO2004046310A2 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 06/03/2004 | WO2004046222A1 Modified biological substance, process for producing the same, and intermediate |
| 06/03/2004 | WO2004046184A1 Process for the purification of tnf-binding proteins using imac |
| 06/03/2004 | WO2004046183A2 Identification of an agonist-v1r receptor pair functional in the olfactory system and uses thereof |
| 06/03/2004 | WO2004046182A2 Use of soluble forms of cd83 and nucleic acids encoding them for the treatment or prevention of diseases |
| 06/03/2004 | WO2004046180A2 Chemosensitization by a non-apoptogenic heat shock protein 70-binding apoptosis inducing factor mutant add70 |
| 06/03/2004 | WO2004046179A1 Tyrosine phosphorylation-deficient mutant calmodulin, production method thereof and use of same in biological methods |
| 06/03/2004 | WO2004046178A2 Shrew paralytic peptide for use in neuromuscular therapy |
| 06/03/2004 | WO2004046177A2 Unexpected surface proteins in neisseria meningitidis |
| 06/03/2004 | WO2004046176A1 Vaccine against hcv |
| 06/03/2004 | WO2004046175A1 Vaccine |